NCT00832949 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

References 1
Badley EM. Emerging issues. In: Arthritis and Related Conditions in Ontario: ICES Research Atlas. 2nd ed. Toronto: Institute for Clinical Evaluative Sciences; 2004. 2. Badley EM, Rasooly I, Webster GK. Relative importance of musculoskeletal disorders as a cause of chronic health problems, disability and health care utilization: Findings from the 1990 ontario health survey. Journal of Rheumatology. 1994;3(21):505-14. 3. Badley EM, Webster GK, Rasooly I. The impact of musculoskeletal disorders in the population: Are they aches and pains? findings from the 1990 ontario health survey. Journal of Rheumatology. 1995;4(22):733-9. 4. Bell M. Peer to peer mentoring program: Summary of proposed research. In press 2008. 5. Superio-Cabuslay E, Ward MM, Lorig K. Patient education interventions in osteoarthritis and rheumatoid arthritis: A meta-analytic comparison with nonsteroidal anti-inflammatory drug treatment. Arthritis Care and Research. 1996;9:292-301. 6. Health Canada. Arthritis in canada. an ongoing challenge. Ottawa: Health Canada; 2003. 7. Dennis C. Peer support within a health care context: A concept analysis. International Journal of Nursing Studies. 2003;40:321-32. 8. Osborne RH, Jordan JE, Rogers A. A critical look at the role of self-management for people with arthritis and other chronic diseases. Nature Clinical Practice Rheumatology. 2008;4:224-5. 9. Jordan JM, Lawrence R, Kingston R, Fraser P, Karlson E, Lorig K. Ethnic health disparities in arthritis and musculoskeletal diseases. report of a scientific conference. Arthritis & Rheumatology. 2002;46(9):2280-6.

Exploring the Learning Needs of Individuals With Inflammatory Arthritis From the Perspectives of Patients, Family Members and Friends, and Health Care Providers: Patient Perspectives (One-on-one Interviews)

Details for clinical trial NCT00832949

Clinical trial NCT00832949 - References